Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Cambridge, USA
200 Tech Street
Cambridge, MA, 02139
USA

People

Founder
Founder & Chairman
President &Founding Chief Executive Officer
President of Research and Development
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Show All People

Investments

Funding

TOTAL $225M
FUNDING TOTAL $225M
Venture Round, 12/2012
Flagship Ventures
$40M
Grant, 10/2013
$24.6M
Private Equity, 11/2013
Flagship Ventures
$135M
Venture Round, 1/2014
Alexion Pharmaceuticals
$25M

Tags

Moderna Therapeutics

Moderna is pioneering messenger RNA therapeutics™, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. This breakthrough platform addresses currently undruggable targets, and offers a superior alternative to existing drug modalities for a wide range of disease conditions.

Moderna has developed a broad intellectual property estate including more than 250 patent applications covering novel nucleotide chemistries and drug compositions. The company plans to develop and commercialize its innovative mRNA drugs through a combination of strategic relationships as well as new formed ventures.

Founded in late 2010 by Flagship VentureLabs, Cambridge-based Moderna is privately held and currently has strategic agreements with AstraZeneca and Alexion Pharmaceuticals.

Recent Milestones

Videos

Above:

The Science Behind Moderna: Messenger RNA Therapeutics™

Added: 2/4/14
Above:

Moderna Featured in “Making a Difference in Health Care” by Harvard Business School

Added: 2/4/14
Above:

What if mRNA Could Be a Drug? Moderna CEO Stephane Bancel at TEDxBeaconStreet

Added: 2/4/14

Screenshots

Moderna Therapeutics screenshot
Above: Moderna Therapeutics
Uploaded: 12/8/12

Sources

  1. Moderna Spins Out mRNA Cancer Drugs Into New Company, Onkaido (xconomy.com) [edit]
  2. Moderna Therapeutics launches with $40M (masshightech.com) [edit]
  3. Moderna Snags $25M DARPA Grant to Fight Pandemics With mRNA Drugs (xconomy.com) [edit]
  4. SEC (sec.gov) [edit]
  5. Alexion invests $25M in Moderna for rare-disease treatment (pbn.com) [edit]
  6. Cash-laden Moderna snags $125M in Alexion RNA deal (fiercebiotech.com) [edit]
Edit This Page
Last Edited 3/27/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy